Estudio de pembrolizumab en participantes pediátricos con un tumor sólido avanzado o linfoma
This is a two-part study of pembrolizumab (MK-3475) in pediatric participants who have any of the following types of cancer: advanced melanoma (6 months to
Estudios Clínicos
This is a two-part study of pembrolizumab (MK-3475) in pediatric participants who have any of the following types of cancer: advanced melanoma (6 months to